Literature DB >> 17169713

Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer.

Cedric F Garland1, Sharif B Mohr, Edward D Gorham, William B Grant, Frank C Garland.   

Abstract

BACKGROUND: There is a north-south gradient in age-adjusted mortality rates of ovarian cancer in the United States, with the highest rates in the Northeast and the lowest in the South through Southwest. This suggests that lower levels of solar irradiance might be associated with higher risk of ovarian cancer. Laboratory findings also suggest that low levels of vitamin D metabolites could play a role in the etiology of ovarian cancer.
METHODS: The association of solar ultraviolet B (UVB) irradiance, stratospheric column ozone, and fertility rates at ages 15 to 19 years with incidence rates of ovarian cancer in 175 countries in 2002 were examined using multiple linear regression in 2006.
RESULTS: Age-adjusted ovarian cancer incidence rates generally were highest in countries located at higher latitudes (R(2)=0.45, p< or =0.01). According to multivariate analysis, UVB irradiance (p< or =0.002) and fertility rates at ages 15 to 19 (p=0.01) were inversely associated with incidence rates, while stratospheric ozone (p< or =0.0008), which reduces transmission of UVB, was positively associated with incidence (R(2)=0.49, p<0.0001).
CONCLUSIONS: Solar UVB irradiance was inversely associated with incidence rates of ovarian cancer in this study, adding new evidence to the theory that vitamin D might play a role in the prevention of ovarian cancer. Cohort studies are needed to confirm this possible association.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169713     DOI: 10.1016/j.amepre.2006.08.018

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  35 in total

1.  Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Michael E Carney; Rachel T Palmieri; Paul D P Pharoah; Honglin Song; Estrid Hogdall; Susanne Kruger Kjaer; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Marc T Goodman
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

2.  In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-07

3.  Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?

Authors:  S Mohapatra; A Saxena; G Gandhi; B C Koner; T Singh; P C Ray
Journal:  Clin Transl Oncol       Date:  2015-03-05       Impact factor: 3.405

4.  25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates.

Authors:  L S Greene-Finestone; C Berger; M de Groh; D A Hanley; N Hidiroglou; K Sarafin; S Poliquin; J Krieger; J B Richards; D Goltzman
Journal:  Osteoporos Int       Date:  2010-08-21       Impact factor: 4.507

Review 5.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

6.  Vitamin D affects survival independently of vascular calcification in chronic kidney disease.

Authors:  Daniela Veit Barreto; Fellype Carvalho Barreto; Sophie Liabeuf; Mohammed Temmar; Francis Boitte; Gabriel Choukroun; Albert Fournier; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

7.  Sun exposure and risk of epithelial ovarian cancer.

Authors:  Clara Bodelon; Kara L Cushing-Haugen; Kristine G Wicklund; Jennifer A Doherty; Mary Anne Rossing
Journal:  Cancer Causes Control       Date:  2012-10-12       Impact factor: 2.506

8.  Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study.

Authors:  N Yoshimura; S Muraki; H Oka; M Morita; H Yamada; S Tanaka; H Kawaguchi; K Nakamura; T Akune
Journal:  Osteoporos Int       Date:  2013-05-15       Impact factor: 4.507

9.  Circulating vitamin d and risk of epithelial ovarian cancer.

Authors:  Alan A Arslan; Tess V Clendenen; Karen L Koenig; Johan Hultdin; Kerstin Enquist; Asa Agren; Annekatrin Lukanova; Hubert Sjodin; Anne Zeleniuch-Jacquotte; Roy E Shore; Göran Hallmans; Paolo Toniolo; Eva Lundin
Journal:  J Oncol       Date:  2009-08-27       Impact factor: 4.375

10.  Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.

Authors:  S Tamez; C Norizoe; K Ochiai; D Takahashi; A Shimojima; Y Tsutsumi; N Yanaihara; T Tanaka; A Okamoto; M Urashima
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.